![Merve Dede Profile](https://pbs.twimg.com/profile_images/842573361473503232/rGXB1soN_x96.jpg)
Merve Dede
@drmervedede
Followers
168
Following
1K
Statuses
288
Physician, now also a PhD in MD Anderson Cancer Center | #DoubleDoc
Houston, TX
Joined April 2011
RT @kchenken: Thanks @CellRepMethods for performing very professional review. Our work shows that cells transitioning into new transcriptio…
0
4
0
RT @HindRafei: Please check out our recent “In a Nutshell” article for brief updates on CAR-NK cell therapy for cancer. Lots of new excitin…
0
20
0
RT @TGonatopoulos: Check out our CRISPR genome-scale exon perturbation study @MolecularCell. We identified exons influencing cell fitness a…
0
25
0
RT @rftbsr9: It was an honor to present some of our research and clinical findings at the #CIMT20224 about the role of allogeneic #CARNK ce…
0
3
0
RT @kchenken: Forecasting acute kidney injury and resource utilization in ICU patien... Our recent work that appli…
0
4
0
RT @kchenken: Proud @KChenLab scored #1 in the subtask 2 of this international AI medicine challenge. It took an AI engineer @yukun_tan…
0
4
0
RT @kchenken: Forecasting Acute Kidney Injury and Resource Utilization in ICU patients using longitudinal, multimodal models
0
2
0
RT @rftbsr9: Presenting at the @ESHaematology conference today on off-the-shelf CAR NK cell therapies was an absolute delight. A very compr…
0
2
0
RT @NEJM: Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a great…
0
366
0
RT @may_daher: A labor of love and a true testament to team effort! I hope you enjoy reading it as much as we enjoyed working on it. This w…
0
4
0
RT @HindRafei: Our team is delighted to share with you our most recent work on importance of donor selection for allogeneic CAR NK cell the…
0
11
0
RT @lab_rezvani: Please check out our paper published in @NatureMedicine on our Phase I / II trial with cord blood CAR19/IL15 NK cells. We…
0
81
0
RT @colmr: perspective piece in @NatureGenet with Lovely Paul Solomon Devakumar @stveep and @IcrLordLab. Thinking of synthetic lethality…
0
10
0
RT @colmr: delighted to see @dekegelb's work out in @MolSystBiol! Tumors tolerate astonishing numbers of genetic alterations, including hom…
0
12
0
RT @AzizGwenSancar: Türkiye Cumhuriyeti eğitim sisteminde yetişen gururlu bir fert olarak, Cumhuriyet'imizin 100.yılını yürekten kutluyoru…
0
2K
0
RT @Mercedeh_Mov: 🚀 Exciting news! Our package mbQTL for microbial/pathogenic QTL analysis is out. As pioneers, we've integrated diverse mo…
0
3
0
@TaniguchiMD @Aiims1742 I saw it in Tokyo and was curious myself. Apparently it is from Hirotsu Bio Science company, more info is here:
0
0
3